Skip to content

Henry Ford Heart Score Randomized Trial: Rapid Discharge of Patients Evaluated for Possible Myocardial Infarction

Henry Ford Heart Score Randomized Trial: Rapid Discharge of Patients Evaluated for Possible Myocardial Infarction

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03058120
Enrollment
105
Registered
2017-02-20
Start date
2014-02-19
Completion date
2015-05-08
Last updated
2017-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chest Pain, Coronary Artery Disease, Heart Attack

Brief summary

This was a prospective randomized, controlled trial designed to quantify the reduction in cost and length of stay of early discharge of emergency department patients evaluated for acute myocardial infarction, who are deemed to be low risk based on a modified HEART score (a score that incorporates troponin biomarker, ecg, patient characteristics, and physician clinical judgment).

Detailed description

This was a prospective randomized, controlled trial conducted from February 2014 to May 2015 designed to quantify the reduction in cost and length of stay of early discharge of emergency department patients evaluated for acute myocardial infarction, in those deemed to be low risk based on a modified HEART score. Our study enrolled only those deemed low risk, as these are the patients we believe best served by utilization of the HEART score decision aid. A total of 105 patients evaluated for AMI in the ED with a modified HEART score ≤ 3 (which includes cardiac troponin I \< 0.04 ng/ml at 0 and 3 hours) were randomized to immediate discharge (n = 53) vs management in an observation unit with stress testing (n = 52). The primary endpoints were 30-day total cost and length of stay. Secondary endpoints were all-cause death, nonfatal AMI, rehospitalization for evaluation of possible AMI, and coronary revascularization at 30 days. That such an early discharge strategy would decrease cost and length of stay is intuitively expected; our goal was to quantify such a reduction.

Interventions

OTHERDeferral of admission for stress test

Early discharge; admission and stress test are deferred.

Sponsors

Henry Ford Health System
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* patients 21 years or older * patients who presented to the Emergency Department with symptoms suspicious for AMI. * patients for whom the ED physician's intention to send the patient to the observation unit for stress testing

Exclusion criteria

* Cardiac Troponin I \> 0.04 ng/mL at 0 or 3 hours * clinical presentation warranting admission * inability or unwillingness to consent * trauma as etiology of presenting symptoms.

Design outcomes

Primary

MeasureTime frameDescription
Cost of hospitalization30 daysTotal charges accrued during index hospitalization, as well as costs related to index hospitalization up to 30 days after index discharge
Length of stayup to 1 weekTotal length of stay of index hospitalization

Secondary

MeasureTime frameDescription
30-day MACE30 days after index hospitalizationDeath, non-fatal myocardial infarction, stroke

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 26, 2026